A brand-new all-electric Scheie Eye Institute van offering community-based screening for the four leading causes of blindness is now taking to the streets.
The new form of proton therapy is called FLASH and is designed to deliver cancer-killing radiation therapy in less than a second.
After more than a decade at Penn Medicine, cancer researcher Ronny Drapkin, MD, PhD, will join Wistar as President & CEO in November 2026.
Financial incentives of up to $600 nearly doubled verified quit rates among medically underserved adults undergoing lung cancer screening.
Senior HealthLink, a program pairing seniors with nursing students for regular check-ins, shows that sometimes just showing up is the best medicine.
National awards honor three Penn Medicine faculty for contributions to behavioral medicine, health policy, patient care, and scientific discovery.
Penn Medicine, Philadelphia Soccer 2026, and the U.S. Soccer Foundation opened a hard-court soccer field for the community.
Penn Medicine is helping student-athletes stay in the game while expanding access to care where it is needed most.
“Every kid can do science.” That’s the mission of Jamie Shuda, who has expanded Penn Medicine’s STEM community outreach programs.
Penn Medicine experts explain how later school start times could support teen sleep, learning, safety, and mental health.
Patients think they’re reaching an institution when they message Penn Medicine on social media. What they remember is the person who reached back.
With a focus on strategy and research, Katie Dalke, MD, MBE, and Dovie Watson, MD, MSCE, build on Penn Medicine’s commitment to inclusive care.
Neha Vapiwala, MD, offers lessons for finding purpose throughout one’s professional journey in medicine.
A national review finds uterus transplants have led to dozens of healthy births as surgical outcomes continue to improve.
Many patients with large B-cell lymphoma or follicular lymphoma were still living without a relapse, 10 years after receiving CAR T therapy.
The science of cancer interception is advancing at Penn Medicine with a new platform to develop cancer vaccines piling scientific strength upon strength.
The gift establishes the Middleman Center and Middleman Fund to advance promising discoveries and speed new treatments to patients.
The gift sparks curriculum transformation, new lectureship, and names Entrepreneurship Pathway in honor of alumnus Rod Wong, M03.
The Clayco Foundation award will go toward safety trials of a new small molecule drug aimed at treating RVCL, a rare, fatal disease with no cure.
Stacey Peeples oversees the archives of the nation’s first chartered hospital, home to a nearly three-hundred-year collection of medical artifacts.
At Pennsylvania Hospital, tracing the history of the apothecary shows the importance of professionals helping patients with medicines, then and now.
A pair of early X-ray plates represent the beginning of a revolution in medicine that began at Penn.
Because safety matters inside the hospital and beyond, Penn Medicine across the region is connecting communities with gun locks, safes, and guidance.
From planting to event planning, the LeadIN program teaches Philly teens about environmental justice and leadership skills.
After five years, the Lead-Free Families initiative is proving the impact of a health system investing in safe homes.
Penn’s PATCH program is helping more children access specialized anxiety treatment—by supporting their families first.
When a Jersey Shore lifeguard experienced sudden pain, he never expected it would lead to life saving surgery for him and two of his family members.
Penn’s Southwest Philadelphia crisis response center has expanded access, eased ED crowding, and connected more patients to ongoing mental health support.
Penn Medicine and the University of Miami are leading a $26 million NIH-funded effort to identify early biomarkers of ALS and frontotemporal dementia, with the goal of enabling prevention trials and offering hope to those at genetic risk for these devastating diseases. — Philadelphia Inquirer
Offering smokers up to $600 in financial incentives more than doubled quit rates in a clinical trial led in part by Penn’s Joanna Hart, MD, and Scott Halpern, MD, PhD, with 8% remaining nicotine-free versus 3% or fewer in comparison groups. – Medscape
Carolyn Searles, diagnosed with aggressive breast cancer during pregnancy, was successfully treated with chemotherapy at Penn Medicine and delivered a healthy son. Her story in the 2026 AACR Cancer Progress Report underscores evidence supporting safe cancer treatment during pregnancy. – WHYY
